NTT Expands Its Data Center Footprint By 20%
1.9.2021 11:00:00 EEST | Business Wire | Press release
NTT Ltd.’s Global Data Centers division, a Leader in the IDC MarketScape Worldwide Data Center Colocation and Interconnection Services 2021 Vendor Assessment1, provides a full stack of ICT services and continues to expand its global data center footprint by 20% to build a connected future that will benefit enterprise and hyperscale clients around the world.
NTT operates data centers across Europe, North America, Africa, and Asia, including a major presence in India. It delivers and operates global interconnected data centers with cross regional data center networks through key markets such as London, Singapore, Tokyo, and Virginia in North America. Its expansions in data center services provide increased data center capacity and network connectivity across all geographies, including:
- Americas:
In 2020/21, three new data center campuses were opened in Hillsboro, OR, Santa Clara, CA, and Chicago, IL, in addition to expansion in Ashburn, VA. NTT’s 47-acre (approx. 190,000m2) Hillsboro campus features five data centers with 126MW of planned IT load and Subsea Connect, a trans-pacific network connectivity service that provides connectivity between Hillsboro, Oregon and Tokyo, Japan using NTT’s Pacific Crossing (PC-1) subsea cable system. The Phoenix, AZ campus will open in early 2022 and be the seventh US data center campus. NTT Phoenix PH1 will add 36MW of IT load capacity and is the first of seven planned data centers on the 240MW campus.
- EMEA:
In the past year, NTT has opened new data center buildings in Amsterdam in the Netherlands, and Munich and Frankfurt in Germany, continuing its position as the number one data center provider in the German market. In the UK, the new flagship London 1 Data Center opened in December and, when fully operational, will increase NTT’s capacity by over 200% to support the digital backbone of the UK’s financial services, media, and gaming industries. NTT has also invested in duct and fiber to interconnect all its London data centers.
Over the next two years, NTT will increase its available IT load in EMEA by over 40% as it builds 13 new data center buildings across nine markets in six countries to deliver an added 115MW of IT load across 50,000m2. NTT will launch its first data centers in Madrid and Johannesburg as well as adding buildings to Vienna, Zurich, London and across Germany, with expanded data center interconnections.
- APAC:
Jakarta 3 in Indonesia will launch 15MW at Bekasi, approximately 30km from Central Jakarta, by the end of this year. By taking advantage of NTT’s strengths as a network operator, clients will be able to easily connect with IXs and ISPs. Additionally, Cyberjaya 5 in Malaysia started to provide 6.8MW and plan to expand another 6.8MW to the Cyberjaya campus. In Japan, a new data center with 21MW of IT load capacity has been built in Tokyo. In response to strong demand from its clients, NTT is considering further expansion in Bangkok (Thailand), Osaka Metropolitan area (Japan), and Southern Vietnam.
- India:
With Mumbai 8 going live soon, the Chandivali campus, India’s first operational hyperscale data center park, will reach 85MW of IT load. Over the next 18 months, four new hyperscale data center parks will also become operational: two in Navi Mumbai and one each in Chennai and Delhi, adding approximately 133MW of IT load and 50,000m2 of floorspace. Interconnections for 10 data centers across India will also be rolled out in 2021 and submarine cable landing stations are planned in Mumbai and Chennai. This expansion will further consolidate NTT’s number one position in the Indian market.
In addition to the expansion of NTT’s global data center footprint, NTT is currently constructing a "MIST" large-capacity submarine cable connecting Singapore, Malaysia, and India (Mumbai and Chennai).
The MIST cable system will have a total length of 11,000km: a distance which is further than flying from New York, across the US and the Pacific Ocean to land in Tokyo. Construction will complete in mid-2023.
The infrastructure combination of such a significant increase in global data center capacity coupled with NTT’s status as a tier 1 global network service provider, will provide businesses with a secure platform for increasing full-stack ICT service needs.
Global Data Center Interconnect (GDCI), an integrated global network fabric service that delivers a cross regional data center network and private secure connection to major cloud service providers with a single physical port supporting multiple virtual network services, increases this capability to provide a high speed interconnected digital backbone across its global markets. The increased submarine cable system will also help to provide cross-regional data center interconnections.
Masaaki Moribayashi, President and Board Director for NTT Ltd. said, “The pandemic has dramatically changed our way of life. People’s quality of life now fundamentally depends on this infrastructure. In the next 18 months, NTT plans to increase data center operations by 20% to a total of over 600,000m2 (approx. 6.5M ft2) of floorspace in over 20 countries and regions. In addition, NTT will globally expand approximately 30 connection points of GDCI service in our data centers to optimize the enterprise hybrid cloud environment over NTT’s data centers and network services. NTT has already started construction to add 300MW of IT load to its portfolio. With the completion of new data centers, expanded campuses and high capacity networks such as the MIST submarine cable, we are building a connected future that will benefit NTT's clients around the world.”
To contact us about your project and to see the full extent of NTT’s Global Data Center footprint, services and builds visit https://datacenter.hello.global.ntt
1IDC MarketScape: Worldwide Datacenter Colocation and Interconnection Services 2021
-ENDS-
About the Global Data Centers division of NTT Ltd.
Global Data Centers is a division of NTT Ltd. Our global platform is one of the largest in the world. NTT is recognized as a Leader by IDC in the Worldwide Colocation and Interconnection Services MarketScape, spanning more than 20 countries and regions including North America, Europe, Africa, India and APAC. As a neutral operator, we offer access to multiple cloud providers, a large variety of Internet Exchanges and telecommunication network providers including our own IPv6 compliant, tier-one global IP network. Our clients benefit from tailored infrastructure and experience consistent best practices in design and operations across all of our reliable, scalable and customizable data centers.
Visit us at our new website datacenter.hello.global.ntt.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005069/en/
Contact information
Media Inquiries:
Beth Sissons
Hotwire for NTT Ltd.
T: +44 7824 144 109
E: beth.sissons@hotwireglobal.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
